☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search category
Search here
Search here
Subscribe Now
eli lilly
Eli Lilly Reports the US FDA’s Approval of Kisunla (donanemab-azbt) to Treat Early Symptomatic Alzheimer's Disease
July 3, 2024
Eli Lilly Reports Detailed Data from the P-III (SURMOUNT-OSA) Trial of Tirzepatide to Treat Obstructive Sleep Apnea
June 24, 2024
Eli Lilly Reports the P-II (SYNERGY-NASH) Study Data of Tirzepatide for Treating Metabolic Dysfunction-Associated Steatohepatitis...
June 10, 2024
Eli Lilly Highlights the P-I/II Trial Data of Olomorasib for Treating Advanced Solid Tumors at ASCO 2024
June 3, 2024
Eli Lilly Receives the US FDA’s Approval for Retevmo (Selpercatinib) to Treat Thyroid Cancer or Solid Tumors
May 31, 2024
Eli Lilly Reports Data from Two P-III (QWINT-2 and QWINT-4) Studies of Efsitora for Treating Type 2 Diabetes
May 16, 2024
Load more...
Back to Home